MicroPort CardioFlow Overview
- Year Founded
-
2015
- Status
-
Public
- Employees
-
1,415
- Stock Symbol
-
02160
- Investments
-
5
- Share Price
-
$0.16
- (As of Monday Closing)
MicroPort CardioFlow General Information
Description
MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of VitaFlow, VitaFlow Liberty, Angelguide and AnchorMan. The Group derives revenue from the sales of medical devices through appointed distributors. It derives maximum revenue from PRC.
Contact Information
Website
www.cardioflowmedtech.comCorporate Office
- No. 1601, Zhangdong Road, Zhangjiang Science City
- Pudong New District
- Shanghai, 201203
- China
Corporate Office
- No. 1601, Zhangdong Road, Zhangjiang Science City
- Pudong New District
- Shanghai, 201203
- China
MicroPort CardioFlow Stock Performance
As of 31-Aug-2026, MicroPort CardioFlow’s stock price is $0.16. Its current market cap is $208M with 1.27B shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.16 | $0.18 | $0.12 - $1.02 | $208M | 1.27B | 1.23M | -$0.04 |
MicroPort CardioFlow Financials Summary
As of 31-Dec-2025, MicroPort CardioFlow has a trailing 12-month revenue of $57M.
|
In Thousands, USD |
TTM 31-Dec-2025 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 823,764 | 823,764 | 9,882 | 366,105 |
| Revenue | 57,044 | 57,044 | 50,805 | 47,522 |
| EBITDA | (9,309) | (9,309) | (4,364) | (66,799) |
| Net Income | (18,819) | (18,819) | (6,948) | (66,649) |
| Total Assets | 669,669 | 669,669 | 372,232 | 363,860 |
| Total Debt | 232,235 | 232,235 | 10,692 | 9,950 |
MicroPort CardioFlow Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
MicroPort CardioFlow Comparisons
Industry
Financing
Details
MicroPort CardioFlow Competitors (34)
One of MicroPort CardioFlow’s 34 competitors is Shinva Medical Instrument Company, a Corporation company based in Zibo, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Shinva Medical Instrument Company | Corporation | Zibo, China | ||||
| Endologix | Corporation | Santa Rosa, CA | ||||
| Insight Lifetech | Formerly VC-backed | Shenzhen, China | ||||
| Medtronic | Corporation | Minneapolis, MN | ||||
| Valcare Medical | Venture Capital-Backed | Herzliya, Israel |
MicroPort CardioFlow Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
MicroPort CardioFlow Patents
MicroPort CardioFlow Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025098049-A1 | Delivery apparatus and catheter system thereof | Inactive | 09-Nov-2023 | ||
| AU-2024278950-A1 | Bending control handle and interventional system | Active | 26-May-2023 | ||
| AU-2024278950-B2 | Bending control handle and interventional system | Active | 26-May-2023 | ||
| EP-4696358-A1 | Bending control handle and interventional system | Pending | 26-May-2023 | ||
| EP-4696358-A4 | Bending control handle and interventional system | Pending | 26-May-2023 | A61M25/0105 |
MicroPort CardioFlow Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
MicroPort CardioFlow Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
MicroPort CardioFlow Investments & Acquisitions (5)
MicroPort CardioFlow’s most recent deal was a Secondary Transaction - Private with Shanghai Zuoxin for . The deal was made on 28-Jul-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Shanghai Zuoxin | 28-Jul-2025 | Secondary Transaction - Private | Diagnostic Equipment | ||
| Shanghai Zuoxin | 06-Feb-2024 | Merger/Acquisition | Diagnostic Equipment | ||
| 4C Medical | 15-Nov-2021 | Later Stage VC | Surgical Devices | ||
| Valcare Medical | 22-Jul-2021 | Later Stage VC | Therapeutic Devices | ||
| Valcare Medical | 01-Sep-2018 | Later Stage VC | Therapeutic Devices |
MicroPort CardioFlow ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
28.76 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
MicroPort CardioFlow Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Shanghai Zuoxin | Zhangdong, China | 2019 |
MicroPort CardioFlow FAQs
-
When was MicroPort CardioFlow founded?
MicroPort CardioFlow was founded in 2015.
-
Where is MicroPort CardioFlow headquartered?
MicroPort CardioFlow is headquartered in Shanghai, China.
-
What is the size of MicroPort CardioFlow?
MicroPort CardioFlow has 1,415 total employees.
-
What industry is MicroPort CardioFlow in?
MicroPort CardioFlow’s primary industry is Therapeutic Devices.
-
Is MicroPort CardioFlow a private or public company?
MicroPort CardioFlow is a Public company.
-
What is MicroPort CardioFlow’s stock symbol?
The ticker symbol for MicroPort CardioFlow is 02160.
-
What is the current stock price of MicroPort CardioFlow?
As of 31-Aug-2026 the stock price of MicroPort CardioFlow is $0.16.
-
What is the current market cap of MicroPort CardioFlow?
The current market capitalization of MicroPort CardioFlow is $208M.
-
What is MicroPort CardioFlow’s current revenue?
The trailing twelve month revenue for MicroPort CardioFlow is $57M.
-
Who are MicroPort CardioFlow’s competitors?
Shinva Medical Instrument Company, Endologix, Insight Lifetech, Medtronic, and Valcare Medical are some of the 34 competitors of MicroPort CardioFlow.
-
What is MicroPort CardioFlow’s annual earnings per share (EPS)?
MicroPort CardioFlow’s EPS for 12 months was -$0.04.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
